Th17 Cells in Autoimmune Demyelinating Disease

Overview

Journal Semin Immunopathol

Publisher Springer

Specialties Allergy & Immunology
Pathology

Date 2010 Mar 3

PMID 20195867

Citations 48

Authors

Benjamin Matthew Segal

Affiliations

Soon will be listed here.

Abstract

Recently published studies in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE) have demonstrated an association between the development of demyelinating plaques and the accumulation of Th17 cells in the central nervous system and periphery. However, a causal relationship has been difficult to establish. In fact, in reports published thus far, interleukin (IL)-17A deficiency or neutralization in vivo attenuates, but does not completely abrogate, EAE. There is growing evidence that clinically similar forms of autoimmune demyelinating disease can be driven by myelin-specific T cells of distinct lineages with different degrees of dependence on IL-17A production to achieve their pathological effects. While such observations cast doubts about the potential therapeutic efficacy of Th17 blocking agents in MS, the collective data suggest that IL-17A expression in peripheral blood mononuclear cells could serve as a surrogate biomarker of neuroinflammation and plaque formation and be a useful outcome measure for future clinical trials.

Citing Articles

From Skin and Gut to the Brain: The Infectious Journey of the Human Commensal Fungus Malassezia and Its Neurological Consequences.

Naik B, Sasikumar J, Das S Mol Neurobiol. 2024; 62(1):533-556.

PMID: 38871941 DOI: 10.1007/s12035-024-04270-w.

Auranofin Modulates Thioredoxin Reductase/Nrf2 Signaling in Peripheral Immune Cells and the CNS in a Mouse Model of Relapsing-Remitting EAE.

Al-Kharashi L, Al-Harbi N, Ahmad S, Attia S, Algahtani M, Ibrahim K Biomedicines. 2023; 11(9).

PMID: 37760943 PMC: 10526216. DOI: 10.3390/biomedicines11092502.

The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A.

Fu J, Huang Y, Bao T, Liu C, Liu X, Chen X J Neuroinflammation. 2022; 19(1):98.

PMID: 35459141 PMC: 9034482. DOI: 10.1186/s12974-022-02446-6.

p38 MAP Kinase Signaling in Microglia Plays a Sex-Specific Protective Role in CNS Autoimmunity and Regulates Microglial Transcriptional States.

McGill M, Richman A, Boyd J, Sabikunnahar B, Lahue K, Montgomery T Front Immunol. 2021; 12:715311.

PMID: 34707603 PMC: 8542909. DOI: 10.3389/fimmu.2021.715311.

Effects of Vitamin D and Dexamethasone on Lymphocyte Proportions and Their Associations With Serum Concentrations of 25-Hydroxyvitamin D in Patients With Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder.

Cho E, Shin J, Kwon S, Kim J, Seok J, Kim B Front Immunol. 2021; 12:677041.

PMID: 34394078 PMC: 8358328. DOI: 10.3389/fimmu.2021.677041.

References

Comabella M, Balashov K, Issazadeh S, Smith D, Weiner H, Khoury S . Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J Clin Invest. 1998; 102(4):671-8. PMC: 508928. DOI: 10.1172/JCI3125. View

Ukkonen M, Wu K, Reipert B, Dastidar P, Elovaara I . Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis. Mult Scler. 2007; 13(6):701-7. DOI: 10.1177/1352458506075378. View

Langrish C, Chen Y, Blumenschein W, Mattson J, Basham B, Sedgwick J . IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005; 201(2):233-40. PMC: 2212798. DOI: 10.1084/jem.20041257. View

Cua D, Sherlock J, Chen Y, Murphy C, Joyce B, Seymour B . Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003; 421(6924):744-8. DOI: 10.1038/nature01355. View

Smith T, Hewson A, Kingsley C, Leonard J, Cuzner M . Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. Am J Pathol. 1997; 150(6):1909-17. PMC: 1858331. View

Baron J, Madri J, Ruddle N, Hashim G, Janeway Jr C . Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med. 1993; 177(1):57-68. PMC: 2190872. DOI: 10.1084/jem.177.1.57. View

Hall M, McGlinn E, Coakley G, Fisher S, Boki K, Middleton D . Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun. 2001; 1(3):219-24. DOI: 10.1038/sj.gene.6363661. View

Panitch H, Hirsch R, Haley A, Johnson K . Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet. 1987; 1(8538):893-5. DOI: 10.1016/s0140-6736(87)92863-7. View

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

10.

Ishizu T, Osoegawa M, Mei F, Kikuchi H, Tanaka M, Takakura Y . Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain. 2005; 128(Pt 5):988-1002. DOI: 10.1093/brain/awh453. View

11.

Durelli L, Conti L, Clerico M, Boselli D, Contessa G, Ripellino P . T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann Neurol. 2009; 65(5):499-509. DOI: 10.1002/ana.21652. View

12.

Sonobe Y, Liang J, Jin S, Zhang G, Takeuchi H, Mizuno T . Microglia express a functional receptor for interleukin-23. Biochem Biophys Res Commun. 2008; 370(1):129-33. DOI: 10.1016/j.bbrc.2008.03.059. View

13.

Willenborg D, Fordham S, Staykova M, Ramshaw I, Cowden W . IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol. 1999; 163(10):5278-86. View

14.

Deshpande P, King I, Segal B . IL-12 driven upregulation of P-selectin ligand on myelin-specific T cells is a critical step in an animal model of autoimmune demyelination. J Neuroimmunol. 2006; 173(1-2):35-44. DOI: 10.1016/j.jneuroim.2005.11.016. View

15.

Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S . Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler. 1999; 5(2):101-4. DOI: 10.1177/135245859900500206. View

16.

Vaknin-Dembinsky A, Balashov K, Weiner H . IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol. 2006; 176(12):7768-74. DOI: 10.4049/jimmunol.176.12.7768. View

17.

Khoury S, Hancock W, Weiner H . Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,.... J Exp Med. 1992; 176(5):1355-64. PMC: 2119419. DOI: 10.1084/jem.176.5.1355. View

18.

Merrill J, Kono D, Clayton J, Ando D, Hinton D, Hofman F . Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci U S A. 1992; 89(2):574-8. PMC: 48281. DOI: 10.1073/pnas.89.2.574. View

19.

Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H . Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002; 8(5):500-8. DOI: 10.1038/nm0502-500. View

20.

Khoruts A, Miller S, Jenkins M . Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J Immunol. 1995; 155(10):5011-7. View